Zealand Pharma A/s
(OTC) ZLDPF
Zealand Pharma A/s Financials at a Glance
Market Cap
$3.22B
Revenue (TTM)
$9.21B
Net Income (TTM)
$6.46B
EPS (TTM)
$13.64
P/E Ratio
3.27
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Price
$45.63
Volume
23,072
Open
$45.72
Price
$45.63
Volume
23,072
Open
$45.72
Previous Close
$45.63
Daily Range
$45.14 - $46.55
52-Week Range
$35.93 - $83.12
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Price
$45.63
Volume
23,072
Open
$45.72
Previous Close
$45.63
Daily Range
$45.14 - $46.55
52-Week Range
$35.93 - $83.12
ZLDPF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zealand Pharma A/s
Industry
Biotechnology
Sector
Health CareEmployees
481
CEO
Adam Sinding Steensberg, MD, MBA
Website
www.zealandpharma.comHeadquarters
Copenhagen, 2860, DK
ZLDPF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
76%
Net Income Margin
70%
Return on Equity
56%
Return on Capital
44%
Return on Assets
39%
Earnings Yield
30.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.22B
Shares Outstanding
70.62M
Volume
23.07K
Short Interest
0.00%
Avg. Volume
2.87K
Financials (TTM)
Gross Profit
$9.17B
Operating Income
$7.14B
EBITDA
$7.17B
Operating Cash Flow
$6.52B
Capital Expenditure
$33.29M
Free Cash Flow
$6.48B
Cash & ST Invst.
$15.07B
Total Debt
$484.88M
Zealand Pharma A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$68.76M
+659.3%
Gross Profit
$60.80M
+603.0%
Gross Margin
88.42%
N/A
Market Cap
$3.22B
N/A
Market Cap/Employee
$8.37M
N/A
Employees
385
N/A
Net Income
$378.26M
-30.0%
EBITDA
$501.51M
-81.0%
Quarterly Fundamentals
Net Cash
$14.59B
+86.2%
Accounts Receivable
$318.96M
+129.5%
Inventory
$0.00
-100.0%
Long Term Debt
$462.30M
+23.0%
Short Term Debt
$22.58M
+40.8%
Return on Assets
39.21%
N/A
Return on Invested Capital
44.06%
N/A
Free Cash Flow
$1.06B
-476.3%
Operating Cash Flow
$1.04B
-476.5%